Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...

Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...

To make the world smarter, happier, and richer. Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches ...

Disclosure: This article does not represent investment advice. The content and materials featured on this page are for educational purposes only. Codename:Pepe is merging AI with memecoin culture, ...

What are Valorant ranks? We’ve taken a deep dive into the Valorant ranking system, to show you how they work, and what the current distribution is. Looking at these figures, we can glean all ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

The certified compatibility is between 10x Genomics’ latest Chromium Universal GEM-X 3’ and GEM-X 5’ single-cell chemistries — which enhance sensitivity while reducing cost per cell — and Oxford ...

"By transforming questions about metabolism into a genomics challenge, we were able to draw a 'wiring map' of adult worm metabolism that revealed numerous novel insights." "The most exciting part ...